Corning Inc (GLW) operating KPIs
GLWNYSEDrawing & Insulating of Nonferrous WireFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 16/3073% above fair value
$123.31−5.57 (-4.32%)
Close on Oct 30, 2026Market cap $106.22BP/E 49.9Yield 0.91%
Corning life Sciences and Emerging Growth Businesses — Segment Net Sales ($M)
Combines Life Sciences ($972M in FY25) with Emerging Growth Businesses ($229M in FY25; Pharmaceutical Technologies, Valor Glass, Velocity Vials) = $1,201M in FY25.
Latest, Q3 '26
290
Period ended Sep 30, 2026
Change on a year earlier
+1.0%
287 in Q3 '25
History
11 quarters
Since Q1 '24
Sources
5
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Life Sciences and Emerging Growth Businesses — Segment Net Sales ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 '26 | Sep 30, 2026 | 290 | +1.0% | Corning Earnings Call Presentation (pres_FY2026Q3.pdf, 2026-10-27) ↗ |
| Q2 '26 | Jun 30, 2026 | 294 | -14.8% | Corning Form 10-Q (filed 2026-07-29) ↗ |
| Q1 '26 | Mar 31, 2026 | 272 | 0.0% | Corning Form 10-Q (filed 2026-05-01) ↗ |
| Q4 '25 | Dec 31, 2025 | 297 | -6.6% | Corning Earnings Call Presentation (pres_FY2026Q1.pdf, 2026-04-28) ↗ |
| Q3 '25 | Sep 30, 2025 | 287 | -4.3% | Corning Earnings Call Presentation (pres_FY2026Q3.pdf, 2026-10-27) ↗ |
| Q2 '25 | Jun 30, 2025 | 345 | +15.8% | Corning Form 10-Q (filed 2026-07-29) ↗ |
| Q1 '25 | Mar 31, 2025 | 272 | -7.8% | Corning Form 10-Q (filed 2026-05-01) ↗ |
| Q4 '24 | Dec 31, 2024 | 318 | – | Corning Form 8-K (filed 2026-04-28) ↗ |
| Q3 '24 | Sep 30, 2024 | 300 | – | Corning Form 8-K (filed 2026-04-28) ↗ |
| Q2 '24 | Jun 30, 2024 | 298 | – | Corning Form 8-K (filed 2026-04-28) ↗ |
| Q1 '24 | Mar 31, 2024 | 295 | – | Corning Form 8-K (filed 2026-04-28) ↗ |
Breakdown
What makes up life sciences and emerging growth businesses — segment net sales
- Life Sciences and Emerging Growth Businesses — Segment Net Income (Loss)-28 · Q3 '26
- Life Sciences and Emerging Growth Businesses — Segment RD&E Expenses27 · Q2 '26
- Life Sciences and Emerging Growth Businesses — Segment Depreciation23 · Q2 '26
- Life Sciences and Emerging Growth Businesses — Segment Income Tax Benefit-6 · Q2 '26
- Life Sciences and Emerging Growth Businesses — Other Segment Items271 · Q2 '26
- Life Sciences and Emerging Growth Businesses — Segment Total Assets (annual)–
- Life Sciences and Emerging Growth Businesses — Segment Capital Expenditures (annual)–
- Life Sciences (Standalone) — Segment Net Sales (legacy through Q4 '25)246 · Q4 '25
- Hemlock and Emerging Growth Businesses — Segment Net Sales (legacy through Q4 '25)526 · Q4 '25
Cite this data
StockData. (2026). Corning Life Sciences and Emerging Growth Businesses — Segment Net Sales ($M), quarterly Q1 '24–Q3 '26 [Data set]. Compiled from Corning SEC filings and investor materials. https://stockdatahq.com/stocks/glw/kpis/lsegb-rev
See every metric in the Corning KPI table. Data updated Oct 28, 2026.